Citigroup’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Sell |
37,583
-57,627
| -61% | -$1.01M | ﹤0.01% | 2766 |
|
|
2025
Q1 | $1.2M | Sell |
95,210
-5,473
| -5% | -$68.9K | ﹤0.01% | 2439 |
|
|
2024
Q4 | $1.06M | Buy |
100,683
+63,461
| +170% | +$670K | ﹤0.01% | 2564 |
|
|
2024
Q3 | $540K | Buy |
37,222
+10,803
| +41% | +$157K | ﹤0.01% | 2944 |
|
|
2024
Q2 | $225K | Sell |
26,419
-71,043
| -73% | -$605K | ﹤0.01% | 3110 |
|
|
2024
Q1 | $996K | Buy |
97,462
+92,223
| +1,760% | +$943K | ﹤0.01% | 2368 |
|
|
2023
Q4 | $28.7K | Buy |
5,239
+3,472
| +196% | +$19K | ﹤0.01% | 4083 |
|
|
2023
Q3 | $6.68K | Sell |
1,767
-18,205
| -91% | -$68.8K | ﹤0.01% | 3932 |
|
|
2023
Q2 | $134K | Sell |
19,972
-33,409
| -63% | -$224K | ﹤0.01% | 3432 |
|
|
2023
Q1 | $348K | Sell |
53,381
-41,633
| -44% | -$271K | ﹤0.01% | 2777 |
|
|
2022
Q4 | $810K | Buy |
95,014
+94,596
| +22,631% | +$807K | ﹤0.01% | 2203 |
|
|
2022
Q3 | $2K | Sell |
418
-322
| -44% | -$1.54K | ﹤0.01% | 4724 |
|
|
2022
Q2 | $3K | Sell |
740
-4,944
| -87% | -$20K | ﹤0.01% | 5006 |
|
|
2022
Q1 | $20K | Sell |
5,684
-1,571
| -22% | -$5.53K | ﹤0.01% | 4407 |
|
|
2021
Q4 | $48K | Buy |
7,255
+4,724
| +187% | +$31.3K | ﹤0.01% | 4320 |
|
|
2021
Q3 | $25K | Buy |
2,531
+1,542
| +156% | +$15.2K | ﹤0.01% | 4388 |
|
|
2021
Q2 | $31K | Buy |
989
+148
| +18% | +$4.64K | ﹤0.01% | 4392 |
|
|
2021
Q1 | $37K | Sell |
841
-14,243
| -94% | -$627K | ﹤0.01% | 4216 |
|
|
2020
Q4 | $699K | Buy |
+15,084
| New | +$699K | ﹤0.01% | 2426 |
|